Ann Liver Transplant.  2022 Nov;2(2):127-131. 10.52604/alt.22.0025.

Migration of synthetic vascular graft used for middle hepatic vein reconstruction during living donor liver transplantation using a modified right liver graft: A collective review of worldwide cases

• Chung YK
• Park CS

• KMID: 2560907
• DOI: http://doi.org/10.52604/alt.22.0025

Abstract

Middle hepatic vein (MHV) reconstruction with an interposition vessel graft has been established as a standard procedure for living donor liver transplantation (LDLT) using a right lobe graft when the donor's MHV trunk is preserved in the donor's remnant liver. Although large-size vein allografts are suitable for MHV reconstruction, their supply is often limited. Various synthetic vascular grafts (SVGs) have been frequently used due to their availability and high patency rates. However, unwanted migration of an SVG into the hollow viscus is an unexpected serious complication. Since its first report in 2011, at least nine case reports or short series of SVG migration following LDLT have been published. Postoperative complications and interventional treatments undertaken are other influencing factors of SVG-associated complications. Contrast-enhanced computed tomography is the best modality for early detection of SVG-related complications including infection and suspected gastrointestinal tract penetration. The second study is endoscopic evaluation of the stomach, duodenum, and other adjacent structures. There is no definite consensus about the treatment of SVG migration into a hollow viscus. The majority of patients undergo definitive treatment including surgical removal. However, some patients without any symptoms or sign are under close observation. In conclusion, the risk of unwanted SVG migration is not negligibly low. Lifelong surveillance is necessary to detect unexpected rare complications in LDLT recipients who have MHV reconstruction using SVG.

Keyword

Hepatic venous congestion; Liver transplantation; Polytetrafluoroethylene; Middle hepatic vein; Hollow viscus

Reference

1. Hwang S, Jung DH, Ha TY, Ahn CS, Moon DB, Kim KH, et al. 2012; Usability of ringed polytetrafluoroethylene grafts for middle hepatic vein reconstruction during living donor liver transplantation. Liver Transpl. 18:955–965. DOI: 10.1002/lt.23456. PMID: 22511404.

2. Yi NJ, Suh KS, Lee HW, Cho EH, Shin WY, Cho JY, et al. 2007; An artificial vascular graft is a useful interpositional material for drainage of the right anterior section in living donor liver transplantation. Liver Transpl. 13:1159–1167. DOI: 10.1002/lt.21213. PMID: 17663413.

3. Ha TY, Hwang S, Jung DH, Ahn CS, Kim KH, Moon DB, et al. 2014; Complications analysis of polytetrafluoroethylene grafts used for middle hepatic vein reconstruction in living-donor liver transplantation. Transplant Proc. 46:845–849. DOI: 10.1016/j.transproceed.2013.10.054. PMID: 24767363.

4. Hsu SC, Thorat A, Yang HR, Poon KS, Li PC, Yeh CC, et al. 2017; Assessing the safety of expanded polytetrafluoroethylene synthetic grafts in living donor liver transplantation: graft migration into hollow viscous organs - diagnosis and treatment options. Med Sci Monit. 23:3284–3292. DOI: 10.12659/MSM.902636. PMID: 28683053. PMCID: PMC5510995.

5. Jung IJ, Hwang S, Ha TY, Song GW, Jung DH, Ahn CS, et al. 2020; Long-term patency and complications of ringed polytetrafluoroethylene grafts used for middle hepatic vein reconstruction in living-donor liver transplantation. Korean J Transplant. 34:31–37. DOI: 10.4285/kjt.2020.34.1.31. PMID: 35770268. PMCID: PMC9186820.

6. Kim MJ, Kim HB, Han JK, Suh KS, Kim SH, Baek JH, et al. 2011; Injuries of adjacent organs by the expanded polytetrafluoroethylene grafts in the venoplasty of middle hepatic veins in living-donor liver transplantation: computed tomographic findings and possible risk factors. J Comput Assist Tomogr. 35:544–548. DOI: 10.1097/RCT.0b013e318227a68a. PMID: 21926846.

7. Sultan AM, Shehta A, Salah T, Elshoubary M, Wahab MA. 2018; Spontaneous migration of thrombosed synthetic vascular graft to the duodenum after living-donor liver transplantation: a case-report. Int J Surg Case Rep. 45:42–44. DOI: 10.1016/j.ijscr.2018.03.013. PMID: 29571064. PMCID: PMC6000742.

8. Sevmiş M, Zarbaliyev E, Yıldız H, Alkara U, Aktaş S, Sevmiş Ş. DOI: 10.1080/00015458.2021.1966185. PMID: 34374632.

9. Koc C, Akbulut S, Bilgic Y, Otan E, Sarici B, Isik B, et al. 2020; Artificial vascular graft migration into hollow viscus organs in patients who underwent right lobe living donor liver transplantation. Acta Chir Belg. 120:404–412. DOI: 10.1080/00015458.2020.1778266. PMID: 32496869.

10. Woo HY, Hong SK, Cho JH, Lee JM, Choi Y, Yi NJ, et al. 2021; Complications of polytetrafluoroethylene graft use in middle hepatic vein reconstruction in living donor liver transplantation: a retrospective, single-centre, long-term, real-world experience. Transpl Int. 34:455–464. DOI: 10.1111/tri.13807. PMID: 33368682.

11. Oh RK, Ahn CS, Moon DB, Ha TY, Song GW, Jung DH, et al. 2022; Asymptomatic migration of Hemashield vascular graft used for middle hepatic vein reconstruction of living donor liver transplantation. Ann Liver Transplant. 2:157–161. DOI: 10.52604/alt.22.0026.